Mark James Litton, Chief Business Officer at ALDER BIOPHARMACEUTICALS INC (ALDR), sold 16,520 shares at $12.33 ($204K) on 2017-10-16, disclosed to the SEC on 2017-10-18.
Open-market sale of $204k ALDR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| ALDR | SELL | 2017-01-20 | $35K | — | Filing → |
| ALDR | SELL | 2017-01-09 | $219K | — | Filing → |
| ALDR | SELL | 2017-01-09 | $51K | — | Filing → |